Bicara Therapeutics CEO (BICA) sells $354k in stock holdings
Published on 4/20/2026
AI Summary
Bicara Therapeutics CEO Mazumdar sold $354,000 worth of the company’s stock. This transaction may indicate a change in confidence or strategy regarding the company's future. The sale could also affect investor sentiment and share price movements for Bicara Therapeutics (BICA). Monitoring such insider trading activities can be crucial for understanding potential market impacts.
Related News
Markets
European shares slip; Mideast tensions impact markets and tech stocks
Jun 5
Earnings
Sotera Health (SHC) Stock Initiated by Goldman Sachs with Buy Rating
Jun 5
Markets
KOSPI Wealth Effect Reaches KRW 43 trillion in 2023
Jun 5
Markets
Blackstone (BX) Restricts BCRED Withdrawals to 5% After 10% Requests
Jun 5